ClinicalTrials.gg
CompletedNCT02698449RemCog-TCUpdated Nov 5, 2026

Neurorehabilitation After Traumatic Brain Injury: Functional Magnetic Resonance Imaging Study

An interventional study of transcranial direct current stimulation and Specific cognitive rehabilitation in Traumatic Brain Injury, sponsored by University Hospital, Toulouse. Completed at 1 site in France. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Other

How we know

Updated Nov 5, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 98 studies in Brain Injuries, Traumatic with a site in France — 23 open to participants now, 25 under way, 2 of them phase 3. Brain Injuries, Traumatic · France.

Enrollment
29th of 66
66 · median 55
Started
2017
with 3 others
No phase
40 of 98
8 open now
Registered
32nd of 98
by date

Among the 98 studies in Brain Injuries, Traumatic with a site in France, this one is the 29th largest by enrollment of the 66 interventional ones that give a count, is one of 4 that started in 2017, is one of 40 with no phase, and was the 32nd registered.

Brain Injuries, Traumatic

1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.

Browse Brain Injuries, Traumatic studies →

Open to participants now

23 of the 98 studies in Brain Injuries, Traumatic with a site in France are open now. Recruiting first, the newest first:

18 more — sign in →

All 23 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 98 studies in Brain Injuries, Traumatic with a site in France, or all of them as a file.
02

Study summary

The current study aims to better understand cerebral plasticity mechanisms to optimize non-pharmacological rehabilitation approaches for patients with traumatic brain injury.

Read the detailed description

Cognitive impairment following moderate to severe traumatic brain injury are usual. To date, cognitive rehabilitation effects on cerebral plasticity and quality of life remain unproven essentially because of methodological biases. Transcranial Direct Current Stimulation is an innovative technique of noninvasive brain stimulation that showed efficacy in literature. The current study want to better understand cerebral plasticity mechanisms to optimize non-pharmacological rehabilitation approaches for patients with traumatic brain injury. The aim in the present study is to assess the effect of rehabilitation combined with Transcranial Direct Current Stimulation provided to traumatic brain injury patients with cognitive impairment on cerebral plasticity using functional magnetic resonance imaging. Effects of rehabilitation and Transcranial Direct Current Stimulation will be observed on functional magnetic resonance imaging activation maps acquired. Relationship between attentional outcomes measured in the neuropsychological assessment and activation extend will be explored.

03

Conditions studied

  • Traumatic Brain Injury
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Moderate to severe traumatic brain injury
  • more than 3 months since the onset
  • Attentional disorders (PASAT test (score ≤ centile 10) and/or CANTAB test (≤ -2 standard deviation)
  • Women having treatment (for the magnetic resonance imaging exam)

Exclusion criteria

Exclusion Criteria:

  • inability to undergo magnetic resonance imaging scan
  • No attentional impairment (PASAT ≥ centile10)
  • Severe depression
  • Neurological disease
  • Major cognitive impairment (aphasia, neglect)
  • Drugs addiction
  • Pregnant women and women having no treatment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
66 participants (actual)

Study arms

  • Experimental
    cognitive rehabilitation + transcranial stimulation

    specific cognitive rehabilitation combined to transcranial direct current stimulation

    Procedure: transcranial direct current stimulation · Procedure: Specific cognitive rehabilitation · Radiation: functional Magnetic Resonance Imaging n-back task

  • Experimental
    cognitive rehabilitation + stimulation sham

    specific cognitive rehabilitation combined to transcranial direct current stimulation sham

    Procedure: Specific cognitive rehabilitation · Procedure: transcranial direct current stimulation sham · Radiation: functional Magnetic Resonance Imaging n-back task

  • Experimental
    placebo rehab + transcranial stimulation

    nonspecific cognitive rehabilitation (placebo rehab) combined to transcranial direct current stimulation

  • Experimental
    placebo rehab + stimulation sham

    nonspecific cognitive rehabilitation (placebo rehab) combined to transcranial direct current stimulation sham

    Procedure: Nonspecific cognitive rehabilitation · Procedure: transcranial direct current stimulation sham · Radiation: functional Magnetic Resonance Imaging n-back task

Interventions

  • Proceduretranscranial direct current stimulation

    intensity provided will be 2 milliampere during 20 minutes using 2 electrodes (7x5cm). Anode electrode will be located on the right prefrontal dorsolateral area; cathode electrode will be located on the left supraorbital area.

  • ProcedureSpecific cognitive rehabilitation

    Specific cognitive rehabilitation will be personalized regarding the cognitive complaint and will include a training part and an ecological part.

  • ProcedureNonspecific cognitive rehabilitation

    Nonspecific cognitive rehabilitation will be focused on representation of body in space.

  • Proceduretranscranial direct current stimulation sham

    the same operation that transcranial direct current stimulating but it is a sham surgery

  • Radiationfunctional Magnetic Resonance Imaging n-back task

    the n-back cognitive task was developed : 3 runs will be provided (0-back, 1-back and 2-back), each will be composed of 8 activation blocks and 8 resting blocks alternatively presented.

06

What researchers measure

Primary outcomes

  1. intergroup difference on cerebral map activation in functional magnetic resonance imaging (N-back task).

    Time frame: 12 weeks

Secondary outcomes

  1. Intergroup differences in resting activation maps.

    Time frame: 12 weeks

  2. Intergroup differences in diffusion measures

    Time frame: 12 weeks

  3. Intergroup differences in neuropsychological score

    Time frame: 12 weeks

  4. Correlation between activation extend and attentional outcomes

    Time frame: 12 weeks

  5. Intergroup differences in polymorphisms

    Time frame: 12 weeks

07

Study locations

1 site
  • CHU Toulouse
    Toulouse, 31059, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2017 to primary completion in Jun 2025, 101 months.

Of 445 non-industry interventional studies with no phase under Brain Injuries, Traumatic, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 64. This study's 101 months is above that.

Counting every sponsor, half of 467 studies reached it within 41 months; a quarter within 22 and three quarters within 64.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: primary completion Jul 2023 → Jun 2025 and completion Dec 2023 → Jun 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 18, 2016
First posted
Mar 3, 2016
StartActual
Jan 24, 2017
Primary completionActual
Jun 25, 2025was Jul 2023
CompletionActual
Jun 25, 2025was Dec 2023
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Completed
changed Nov 5, 2026
Primary completion
Jul 2023→Jun 25, 2025 (actual)
Nov 5, 2026
Study completion
Dec 2023→Jun 25, 2025 (actual)
Nov 5, 2026
Enrollment
80 (estimated)→66 (actual)
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Status unknown→Completed
    Primary completion Jul 2023→Jun 25, 2025 (now actual)
    Study completion Dec 2023→Jun 25, 2025 (now actual)
    Enrollment 80 (estimated)→66 (actual)
    + 6 other changes: verification date, design details, arm descriptions, contact details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT02698449
Collaborators
Fondation de l'Avenir
Responsible party
Sponsor
First posted
Mar 3, 2016
Start date
Jan 24, 2017
Primary completion
Jun 25, 2025
Completion
Jun 25, 2025
Last update
Nov 5, 2026

Study contacts

Jérémie Pariente, PhD
principal investigator · University Hospital, Toulouse

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion